SHERBROOKE, Quebec--(BUSINESS WIRE)--Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery and development of novel drug candidates based on proprietary macrocyclic chemistry, announced today the signing of a drug discovery collaboration agreement with Astellas Pharma Inc., one of the world’s leading pharmaceutical discovery and development companies. The collaboration, planned for an initial two year term, will exploit Cyclenium’s proprietary QUEST Library™ of next generation synthetic small-molecule macrocycles and associated optimization expertise to identify clinical candidates effective against multiple pharmacological targets selected by Astellas in their therapeutic focus areas.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
